Claudio Papi
Claudio Papi
UOS Malattie infiammatorie croniche dell'intestino, UOC Gastroenterologia Osp. S Filippo Neri, Roma
Email verificata su
Citata da
Citata da
Hepatitis B virus replication
J Beck, M Nassal
World journal of gastroenterology: WJG 13 (1), 48, 2007
Evidence-based appraisal of antireflux fundoplication
M Catarci, P Gentileschi, C Papi, A Carrara, R Marrese, AL Gaspari, ...
Annals of surgery 239 (3), 325, 2004
Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis
C Papi, M Catarci, L D'ambrosio, L Gili, M Koch, GB Grassi, L Capurso
American Journal of gastroenterology 99 (1), 147-155, 2004
Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease
M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ...
Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study
G Corrao, A Tragnone, R Caprilli, G Trallori, C Papi, A Andreoi, ...
International journal of epidemiology 27 (3), 397-404, 1998
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial
C Papi, A Ciaco, M Koch, L Capurso
Alimentary pharmacology & therapeutics 9 (1), 33-39, 1995
Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study
L Biancone, A Orlando, A Kohn, E Colombo, R Sostegni, E Angelucci, ...
Gut 55 (2), 228-233, 2006
Colectomy rate in acute severe ulcerative colitis in the infliximab era
A Aratari, C Papi, V Clemente, A Moretti, R Luchetti, M Koch, L Capurso, ...
Digestive and Liver Disease 40 (10), 821-826, 2008
Meta‐analysis: long‐term therapy with rifaximin in the management of uncomplicated diverticular disease
M Bianchi, V Festa, A Moretti, A Ciaco, M Mangone, V Tornatore, A Dezi, ...
Alimentary pharmacology & therapeutics 33 (8), 902-910, 2011
Budesonide in the treatment of Crohn’s disease: a meta‐analysis
C Papi, R Luchetti, L Gili, S Montanti, M Koch, L Capurso
Alimentary pharmacology & therapeutics 14 (11), 1419-1428, 2000
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor…
A Orlando, A Armuzzi, C Papi, V Annese, S Ardizzone, L Biancone, ...
Digestive and Liver Disease 43 (1), 1-20, 2011
Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis?: A meta-analysis of randomized controlled trials
A Moretti, C Papi, A Aratari, V Festa, M Tanga, M Koch, L Capurso
Digestive and liver disease 40 (5), 379-385, 2008
Early versus late surgery for ileo‐caecal Crohn’s disease
A Aratari, C Papi, G Leandro, A Viscido, L Capurso, R Caprilli
Alimentary pharmacology & therapeutics 26 (10), 1303-1312, 2007
Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial
R Caprilli, M Cottone, F Tonelli, G Sturniolo, F Castiglione, V Annese, ...
Alimentary pharmacology & therapeutics 17 (4), 517-523, 2003
Crucial steps in the natural history of inflammatory bowel disease
G Latella, C Papi
World journal of gastroenterology: WJG 18 (29), 3790, 2012
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study
A Orlando, E Colombo, A Kohn, L Biancone, F Rizzello, A Viscido, ...
Digestive and liver disease 37 (8), 577-583, 2005
Infliximab in refractory pouchitis complicated by fistulae following ileo‐anal pouch for ulcerative colitis
A Viscido, FI Habib, A Kohn, C Papi, A Marcheggiano, MT Pimpo, ...
Alimentary pharmacology & therapeutics 17 (10), 1263-1271, 2003
Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis
G Riegler, MT Tartaglione, R Carratu, R D'inc, D Valpiani, MI Russo, ...
Digestive diseases and sciences 45 (3), 462-465, 2000
Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group.
C Papi, A Ciaco, M Koch, L Capurso
The Italian journal of gastroenterology 24 (8), 452-456, 1992
Adalimumab in active ulcerative colitis: a “real-life” observational study
A Armuzzi, L Biancone, M Daperno, A Coli, D Pugliese, V Annese, ...
Digestive and Liver Disease 45 (9), 738-743, 2013
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20